Pfizer and a United Nations-backed group announced Monday that the drugmaker would let outside companies make its COVID-19 pill.
“Pfizer remains committed to bringing forth scientific breakthroughs to help end this pandemic for all people. We believe oral antiviral treatments can play a vital role in reducing the severity of COVID-19 infections, decreasing the strain on our healthcare systems, and saving lives,” Albert Bourla, chairman and CEO of Pfizer, said in a statement.
